Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG)

Yıl: 2017 Cilt: 18 Sayı: 4 Sayfa Aralığı: 242 - 250 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG)

Öz:
Objective: The present study was designed to evaluate the characteristics of pulmonary hypertension (PH) and adult cardiology practice patterns for PH in our country.Methods: We evaluated preliminary survey data of 1501 patients with PH (females, 69%; age, 44.8±5.45) from 20 adult cardiology centers (AdCCs).Results: The average experience of AdCCs in diagnosing and treating patients with PH was 8.5±3.7 years. Pulmonary arterial hypertension (PAH) was the most frequent group (69%) followed by group 4 PH (19%), group 3 PH (8%), and combined pre- and post-capillary PH (4%). PAH associated with congenital heart disease (APAH-CHD) was the most frequent subgroup (47%) of PAH. Most of the patients' functional class (FC) at the time of diagnosis was III. The right heart catheterization (RHC) rate was 11.9±11.6 per month. Most frequently used vasoreactivity agent was intravenous adenosine (60%). All patients under targeted treatments were periodically for FC, six-minute walking test, and echo measures at 3-month intervals. AdCCs repeated RHC in case of clinical worsening (CW). The annual rate of hospitalization was 14.9±19.5. In-hospital use of intravenous iloprost reported from 16 AdCCs in CWs. Bosentan and ambrisentan, as monotreatment or combination treatment (CT), were noted in 845 and 28 patients, respectively, and inhaled iloprost, subcutaneous treprostinil, and intravenous epoprostenol were noted in 283, 30, and four patients, respectively. Bosentan was the first agent used for CT in all AdCCs and iloprost was the second. Routine use of antiaggregant, anticoagulant, and pneumococcal and influenza prophylaxis were restricted in only two AdCCs.Conclusion: Our nationwide data illustrate the current status of PH regarding clinical characteristics and practice patterns.
Anahtar Kelime:

Konular: Kalp ve Kalp Damar Sistemi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
0
0
0
  • 1. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Primary pulmonary hypertension:a national prospective study. Ann Intern Med 1987; 107: 216-23.
  • 2. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991; 115: 343-9.
  • 3. Galie` N, Manes A, Negro L, Palazzini M, Bacchi-Reggiani ML, Branzi A. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J 2009; 30: 394-403.
  • 4. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006; 173: 1023-30.
  • 5. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, et al. Survival in patients with idiopathic, familial, and anorexigenassociated pulmonary arterial hypertension in the modern management era. Circulation 2010; 122: 156-63.
  • 6. Jing ZC, Xu XQ, Han ZY, Wu Y, Deng KW, Wang H, et al. Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest 2007; 132: 373-9.
  • 7. Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J 2007; 30: 104-9.
  • 8. Escribano-Subias P, Blanco I, Lopez-Meseguer M, Lopez-Guarch CJ, Roman A, Morales P, et al. Survival in pulmonary hypertension in Spain: insights from the Spanish registry. Eur Respir J 2012; 40: 596-603.
  • 9. Thenappan T, Shah SJ, Rich S, Tian L, Archer SL, Gomberg-Maitland M. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. Eur Respir J 2010; 35: 1079- 87.
  • 10. Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry. Chest 2010; 137: 376-87.
  • 11. Frost AE, Badesch DB, Barst RJ, Benza RL, Elliott CG, Farber HW, et al. The changing picture of patients with pulmonary arterial hypertension in the United States: How REVEAL differs from historic and non-US Contemporary Registries. Chest 2011; 139: 128-37.
  • 12. Galie` N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines on diagnosis and treatment of pulmonary hypertension: the Task Force on Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology and of the European Respiratory Society. Eur Heart J 2009; 30: 2493-537.
  • 13. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al, ACCF/AHA. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009; 119: 2250-94.
  • 14. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62: D34-41.
  • 15. Galie` N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Eur Heart J 2016; 37: 67-119.
  • 16. Kaymaz C, Özdemir N, Kırma C, Akdemir I, Özkan M. Pulmonary artery thrombi detected by echocardiography in patients with pulmonary hypertension secondary to atrial septal defect. Eur J Echocardiogr 2001; 2: 149-53.
  • 17. Kayıkçıoğlu M, Kültürsay H. Seven years of experience in patients with pulmonary arterial hypertension in Ege University Hospital: Diagnostic approach of a single center. Anadolu Kardiyol Derg 2008; 8: 279-85.
  • 18. Can MM, Kaymaz C, Tanboğa IH, Tokgöz HC, Canpolat N, Türkyılmaz E, et al. Increased right ventricular glucose metabolism in patients with pulmonary arterial hypertension. Clin Nucl Med 2011; 36: 743- 8.
  • 19. Yıldızeli B, Taş S, Yanartaş M, Kaymaz C, Mutlu B, Karakurt S, et al. Pulmonary endarterectomy for chronic thrombo-embolic pulmonary hypertension: an institutional experience. Eur J Cardiothorac Surg 2013; 44: e219-27.
  • 20. Can MM, Tanboğa IH, Tokgöz HC, Özkan A, Koca F, Keleş N, et al. Enhanced hemostatic indices in patients with pulmonary arterial hypertension: An observational study. Thromb Res 2010; 126: 280-2.
  • 21. Sünbül M, Kıvrak T, Durmuş E, Yıldızeli B, Mutlu B. Evaluation of right and left heart mechanics in patients with chronic thromboembolic pulmonary hypertension before and after pulmonary thromboendarterectomy. Int J Cardiovasc Imaging 2015; 31: 1159-67.
  • 22. Sünbül M, Kepez A, Kıvrak T, Eroğlu E, Özben B, Yıldızeli B, et al. Right ventricular longitudinal deformation parameters and exercise capacity: prognosis of patients with chronic thromboembolic pulmonary hypertension. Herz 2014; 39: 470-5.
  • 23. Küçükoğlu S, Saylam GS, Kaymaz C, Alehan D, Kula S, Akçevin A, et al. Clinical characteristics of pulmonary arterial hypertension (PAH) associated with congenital heart disease: baseline results from the THALES (Turkish Congenital Heart Disease-associated PAH) Registry. Eur Heart J 2012; 33 (Abstract Supplement): 420, P2522.
  • 24. Kaymaz C, Küçükoğlu S, Kula S, Alehan D, Saylam GS, Akçevin A, et al. The inaccuracy of Doppler echo estimates of pulmonary arterial pressures in patients with pulmonary arterıal hypertension associated with congenital heart disease:insights from a large multicenter study. J Am Coll Cardiol 2013; 61: E1270.
  • 25. Küçükoğlu S, Kaymaz C, Saylam GS, Kula S, Alehan D, Akçevin A, et al. The quantification of functional class and the six-minute walking distance in pulmonary arterial hypertension associated with congenital shunts: Clinical and hemodynamic correlates. J Am Coll Cardiol 2013; 61: 1208-54, E1269.
  • 26. Kaymaz C, Öztürk S, Poci N, Aktemur T, Akbal O, Tokgöz Demircan HC, et al. The right to left atrial and ventricular area ratio, left ventricular area,TAPSE and right ventricular global strain can predict three-year survival in patients with pulmonary hypertension. Eur Heart J 2013; 34: 47, P327.
  • 27. Kaymaz C, Aktemur T, Poci T, Öztürk S, Akbal OY, Yılmaz F, et al. The clinical relevance of the simplified pulmonary vascular resistance to systemic vascular resistance ratio using the transpulmonary and transsystemic pressure gradients and Qp/Qs ratio in patients with pulmonary hypertension. J Am Coll Cardiol 2014; 63: A1496.
  • 28. Kaymaz C, Uslu Z, Kırca N, Aktemur T, Poçi N, Öztürk S, et al. The recruitment of systemic-to-pulmonary collaterals in chronic and severe pulmonary hypertension as an adaptive mechanism: Do we treat these collaterals in reality? J Am Coll Cardiol 2014; 63: A1473.
  • 29. Kaymaz C, Poçi N, Aktemur T, Öztürk S, Akbal OY, Yılmaz F, et al. The decrease in plasma brain natriuretic peptide level in response to intravenous iloprost during clinical worsening may predict outcome in pulmonary hypertension. J Am Coll Cardiol 2014; 63: A1503.
  • 30. Kaymaz C, Öztürk S, Akbal OY, Poçi N, Aktemur T, Yılmaz F, et al. The pulmonary vascular resistance and pulmonary vascular resistance to systemic resistance ratio but not diastolic pulmonary gradient, may predict survival in patients with pulmonary hypertension: Insights from a single-center study J Am Coll Cardiol 2015; 65: A1562.
  • 31. Kaymaz C, Akbal OY, Poci N, Türkday S, Öztürk S, Kalamanoğlu Balcı M, et al. Pulmonary hypertension connection formula provides a more realistic eight-year survival estimates than national institute of health and french registry equations. Eur Heart J 2015; 36 (Abstract Supplement): 965-6, P5517.
  • 32. Frost AE, Farber HW, Barst RJ, Miller DP, Elliott CG, McGoon MD. Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mm Hg: insights from the REVEAL Registry. Chest 2013; 143: 185-95.
  • 33. Kim NH, Delcroix M, Jenkins DP, Channick R, Dartevelle P, Jansa P, et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 2013; 62: D92-9.
  • 34. Mayer E, Jenkins D, Lindner J, D'Armini A, Kloek J, Meyns B, et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg 2011; 141: 702-10.
  • 35. Madani MM, Auger WR, Pretorius V, Sakakibara N, Kerr KM, Kim NH, et al. Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients. Ann Thorac Surg 2012; 94:97-103.
  • 36. Galie` N, Corris PA, Frost A, Girgis RE, Granton J, Jing ZC, et al. Updated treatment algorithm of pulmonary hypertension. J Am Coll Cardiol 2013; 62(Suppl): D60-72.
  • 37. Barst RJ, Galie N, Naeije R, Simonneau G, Jeffs R, Arneson C, et al. Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil. Eur Respir J 2006; 28: 1195- 203.
  • 38. Farber HW, Miller DP, Meltzer LA, McGoon MD. Treatment of patients with pulmonary arterial hypertension at the time of death or deterioration to functional class IV: insights from the REVEAL Registry. J Heart Lung Transplant 2013; 32: 1114-22.
APA KAYMAZ C, MUTLU B, KÜÇÜKOĞLU M, KAYA E, AKDENİZ B, AVCI KILIÇKIRAN B, Aksakal E, AKBULUT M, ARITÜRK ATILGAN Z, GÜLLÜLÜ S, TAÇOY G, KAYIKÇIOĞLU L, Nalbantgil S, örem C, ERER H, YÜCE M, ERMİŞ N, TÜFEKÇİOĞLU O, Demir M, YILMAZ M, KULTURSAY H, ÖNGEN Z, TOKGÖZOĞLU S (2017). Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG). , 242 - 250.
Chicago KAYMAZ Cihangir,MUTLU Bülent,KÜÇÜKOĞLU M. Serdar,KAYA ERGUN BARIS,AKDENİZ Bahri,AVCI KILIÇKIRAN Burçak,Aksakal Enbiya,AKBULUT MEHMET,ARITÜRK ATILGAN Zehra,GÜLLÜLÜ Sümeyye,TAÇOY GÜLTEN,KAYIKÇIOĞLU LATİFE MERAL,Nalbantgil Sanem,örem Cihan,ERER Hatice Betül,YÜCE Murat,ERMİŞ Necip,TÜFEKÇİOĞLU Omaç,Demir Mesut,YILMAZ MEHMET BIRHAN,KULTURSAY HAKAN,ÖNGEN Zeki,TOKGÖZOĞLU SADBERK LALE Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG). (2017): 242 - 250.
MLA KAYMAZ Cihangir,MUTLU Bülent,KÜÇÜKOĞLU M. Serdar,KAYA ERGUN BARIS,AKDENİZ Bahri,AVCI KILIÇKIRAN Burçak,Aksakal Enbiya,AKBULUT MEHMET,ARITÜRK ATILGAN Zehra,GÜLLÜLÜ Sümeyye,TAÇOY GÜLTEN,KAYIKÇIOĞLU LATİFE MERAL,Nalbantgil Sanem,örem Cihan,ERER Hatice Betül,YÜCE Murat,ERMİŞ Necip,TÜFEKÇİOĞLU Omaç,Demir Mesut,YILMAZ MEHMET BIRHAN,KULTURSAY HAKAN,ÖNGEN Zeki,TOKGÖZOĞLU SADBERK LALE Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG). , 2017, ss.242 - 250.
AMA KAYMAZ C,MUTLU B,KÜÇÜKOĞLU M,KAYA E,AKDENİZ B,AVCI KILIÇKIRAN B,Aksakal E,AKBULUT M,ARITÜRK ATILGAN Z,GÜLLÜLÜ S,TAÇOY G,KAYIKÇIOĞLU L,Nalbantgil S,örem C,ERER H,YÜCE M,ERMİŞ N,TÜFEKÇİOĞLU O,Demir M,YILMAZ M,KULTURSAY H,ÖNGEN Z,TOKGÖZOĞLU S Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG). . 2017; 242 - 250.
Vancouver KAYMAZ C,MUTLU B,KÜÇÜKOĞLU M,KAYA E,AKDENİZ B,AVCI KILIÇKIRAN B,Aksakal E,AKBULUT M,ARITÜRK ATILGAN Z,GÜLLÜLÜ S,TAÇOY G,KAYIKÇIOĞLU L,Nalbantgil S,örem C,ERER H,YÜCE M,ERMİŞ N,TÜFEKÇİOĞLU O,Demir M,YILMAZ M,KULTURSAY H,ÖNGEN Z,TOKGÖZOĞLU S Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG). . 2017; 242 - 250.
IEEE KAYMAZ C,MUTLU B,KÜÇÜKOĞLU M,KAYA E,AKDENİZ B,AVCI KILIÇKIRAN B,Aksakal E,AKBULUT M,ARITÜRK ATILGAN Z,GÜLLÜLÜ S,TAÇOY G,KAYIKÇIOĞLU L,Nalbantgil S,örem C,ERER H,YÜCE M,ERMİŞ N,TÜFEKÇİOĞLU O,Demir M,YILMAZ M,KULTURSAY H,ÖNGEN Z,TOKGÖZOĞLU S "Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG)." , ss.242 - 250, 2017.
ISNAD KAYMAZ, Cihangir vd. "Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG)". (2017), 242-250.
APA KAYMAZ C, MUTLU B, KÜÇÜKOĞLU M, KAYA E, AKDENİZ B, AVCI KILIÇKIRAN B, Aksakal E, AKBULUT M, ARITÜRK ATILGAN Z, GÜLLÜLÜ S, TAÇOY G, KAYIKÇIOĞLU L, Nalbantgil S, örem C, ERER H, YÜCE M, ERMİŞ N, TÜFEKÇİOĞLU O, Demir M, YILMAZ M, KULTURSAY H, ÖNGEN Z, TOKGÖZOĞLU S (2017). Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG). The Anatolian Journal of Cardiology, 18(4), 242 - 250.
Chicago KAYMAZ Cihangir,MUTLU Bülent,KÜÇÜKOĞLU M. Serdar,KAYA ERGUN BARIS,AKDENİZ Bahri,AVCI KILIÇKIRAN Burçak,Aksakal Enbiya,AKBULUT MEHMET,ARITÜRK ATILGAN Zehra,GÜLLÜLÜ Sümeyye,TAÇOY GÜLTEN,KAYIKÇIOĞLU LATİFE MERAL,Nalbantgil Sanem,örem Cihan,ERER Hatice Betül,YÜCE Murat,ERMİŞ Necip,TÜFEKÇİOĞLU Omaç,Demir Mesut,YILMAZ MEHMET BIRHAN,KULTURSAY HAKAN,ÖNGEN Zeki,TOKGÖZOĞLU SADBERK LALE Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG). The Anatolian Journal of Cardiology 18, no.4 (2017): 242 - 250.
MLA KAYMAZ Cihangir,MUTLU Bülent,KÜÇÜKOĞLU M. Serdar,KAYA ERGUN BARIS,AKDENİZ Bahri,AVCI KILIÇKIRAN Burçak,Aksakal Enbiya,AKBULUT MEHMET,ARITÜRK ATILGAN Zehra,GÜLLÜLÜ Sümeyye,TAÇOY GÜLTEN,KAYIKÇIOĞLU LATİFE MERAL,Nalbantgil Sanem,örem Cihan,ERER Hatice Betül,YÜCE Murat,ERMİŞ Necip,TÜFEKÇİOĞLU Omaç,Demir Mesut,YILMAZ MEHMET BIRHAN,KULTURSAY HAKAN,ÖNGEN Zeki,TOKGÖZOĞLU SADBERK LALE Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG). The Anatolian Journal of Cardiology, vol.18, no.4, 2017, ss.242 - 250.
AMA KAYMAZ C,MUTLU B,KÜÇÜKOĞLU M,KAYA E,AKDENİZ B,AVCI KILIÇKIRAN B,Aksakal E,AKBULUT M,ARITÜRK ATILGAN Z,GÜLLÜLÜ S,TAÇOY G,KAYIKÇIOĞLU L,Nalbantgil S,örem C,ERER H,YÜCE M,ERMİŞ N,TÜFEKÇİOĞLU O,Demir M,YILMAZ M,KULTURSAY H,ÖNGEN Z,TOKGÖZOĞLU S Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG). The Anatolian Journal of Cardiology. 2017; 18(4): 242 - 250.
Vancouver KAYMAZ C,MUTLU B,KÜÇÜKOĞLU M,KAYA E,AKDENİZ B,AVCI KILIÇKIRAN B,Aksakal E,AKBULUT M,ARITÜRK ATILGAN Z,GÜLLÜLÜ S,TAÇOY G,KAYIKÇIOĞLU L,Nalbantgil S,örem C,ERER H,YÜCE M,ERMİŞ N,TÜFEKÇİOĞLU O,Demir M,YILMAZ M,KULTURSAY H,ÖNGEN Z,TOKGÖZOĞLU S Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG). The Anatolian Journal of Cardiology. 2017; 18(4): 242 - 250.
IEEE KAYMAZ C,MUTLU B,KÜÇÜKOĞLU M,KAYA E,AKDENİZ B,AVCI KILIÇKIRAN B,Aksakal E,AKBULUT M,ARITÜRK ATILGAN Z,GÜLLÜLÜ S,TAÇOY G,KAYIKÇIOĞLU L,Nalbantgil S,örem C,ERER H,YÜCE M,ERMİŞ N,TÜFEKÇİOĞLU O,Demir M,YILMAZ M,KULTURSAY H,ÖNGEN Z,TOKGÖZOĞLU S "Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG)." The Anatolian Journal of Cardiology, 18, ss.242 - 250, 2017.
ISNAD KAYMAZ, Cihangir vd. "Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG)". The Anatolian Journal of Cardiology 18/4 (2017), 242-250.